HomeLPGO • STO
add
Lipigon Pharmaceuticals AB
Previous close
kr 0.0054
Day range
kr 0.0056 - kr 0.0070
Year range
kr 0.0040 - kr 0.19
Market cap
2.04M SEK
Avg Volume
6.54M
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.65M | -33.87% |
Net income | -7.18M | 32.98% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -7.20M | 39.39% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 10.21M | -13.26% |
Total assets | 11.49M | -22.51% |
Total liabilities | 3.57M | -49.40% |
Total equity | 7.91M | — |
Shares outstanding | 605.93M | — |
Price to book | 0.54 | — |
Return on assets | -122.17% | — |
Return on capital | -157.04% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -7.18M | 32.98% |
Cash from operations | -6.38M | -699.34% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -6.38M | -714.34% |
Free cash flow | -3.74M | -187.13% |
About
Founded
2010
Website
Employees
7
